Helicore Biopharma, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics to address obesity and related metabolic conditions.
The company is advancing a portfolio of next-generation treatments with a novel approach to glucose-dependent insulinotropic peptide (GIP) antagonism. Helicore’s proprietary platform leverages monoclonal antibodies that bind circulating GIP ligand, designed to improve the efficacy, dosing, and tolerability of anti-obesity therapies.
Helicore is rapidly advancing a differentiated portfolio that may deliver superior treatment outcomes through enhanced efficacy, tolerability and convenient dosing regimens.
Following the close of a $65M Series A financing in January 2024, Helicore is well-positioned to drive progress in this critical area of unmet need. For more information, visit www.helicore.com.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 1825 South Grant Street, San Mateo,ca 94402,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.helicore.com
- Keywords
- obesity, anti-obesity, glucose-dependent insulinotropic polypeptide, GIP, GIP antagonist, GIP antagonism, GIP ligand binding, GIP neutralization, GIP conjugate, GLP-1, HCR-188, gut peptides, leptin resistance, type 2 diabetes, cardiometabolic, weight-loss therapies, incretin hormones, biologics, drug discovery, biopharmaceutical.
- HQ
- San Mateo, CA
Helicore Biopharma Questions
Helicore Biopharma's website is http://www.helicore.com
Helicore Biopharma's LinkedIn profile is https://www.linkedin.com/company/helicore-biopharma
Helicore Biopharma has
7 employees.
View email and phone details for 7
employees at Helicore Biopharma.
Helicore Biopharma's industry is
Biotechnology Research
Helicore Biopharma's top competitors are
Ouro Medicines,
89bio,
Abcuro, Inc,
Light Horse Therapeutics,
Verdiva Bio,
Xylocor Therapeutics, Inc.,
Akero Therapeutics,
Timberlyne Therapeutics,
Newleos Therapeutics,
Atalanta Therapeutics.
Helicore Biopharma's categories are Biotechnology Research
Helicore Biopharma's founding year is 2025
